Starcrest Education Limited Cancellation of Proposed Acquisition (6869R)

TIDMOBOR

RNS Number : 6869R

Starcrest Education Limited

30 October 2023

30 October 2023

Starcrest Education Limited

("Starcrest" or the "Company" or the "Group")

Cancellation of Proposed Acquisition of Fairview IB World Schools

Starcrest Education Limited (LSE: OBOR , the international developer and operator of education services in Europe, announces the cancellation of its intended acquisition of Fairview IB World Schools ("Fairview"). The Proposed Acquisition was initially announced on 23 March 2022.

Starcrest, subject to matters including but not limited to legal and financial due diligence, agreed to acquire an interest in several Fairview IB World Schools (the "Proposed Acquisition"), which would have amounted to a reverse takeover under the Listing Rules.

Suspension

The suspension of trading in the Company's ordinary shares will remain in place until publication of the audited financial statement for the year ended 31 December 2022 and the unaudited interim results for the period ended 30 June 2023.

Further updates will be provided in due course, as necessary.

- Ends -

Enquiries:

 
 Starcrest Education 
  Jeff Zhang, Executive Director    [phone] 
 Yellow Jersey PR (Financial PR) 
  Sarah Hollins 
  Bessie Elliot                     [phone] 
 

Notes to editors:

Starcrest is an international developer and operator of education services in Europe. The Company was established to seek acquisition opportunities in the international education sector and to provide premier education services and products in the UK and to countries in Europe.

Starcrest listed on the Main Market of the London Stock Exchange on 31 January 2019 under the ticker symbol (LSE: OBOR). Further information can be found on the Company's website at https://www.starcresteducation.com .

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

MSCGLBDGISXDGXG

(END) Dow Jones Newswires

October 30, 2023 03:00 ET (07:00 GMT)